Brown Advisory Inc Neurocrine Biosciences Inc Transaction History

Brown Advisory Inc

  • $77.3 Billion
  • Q3 2024

A detailed history of Brown Advisory Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Brown Advisory Inc holds 942,147 shares of NBIX stock, worth $118 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
942,147
Previous 995,214 5.33%
Holding current value
$118 Million
Previous $137 Million 20.83%
% of portfolio
0.14%
Previous 0.18%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$114.58 - $153.15 $6.08 Million - $8.13 Million
-53,067 Reduced 5.33%
942,147 $108 Million
Q2 2024

Aug 14, 2024
SELL
$130.86 - $143.19 $12.2 Million - $13.3 Million
-93,119 Reduced 8.56%
995,214 $137 Million
Q1 2024

Apr 24, 2024
SELL
$130.4 - $143.74 $3.27 Million - $3.6 Million
-25,080 Reduced 2.25%
1,088,333 $150 Million
Q4 2023

Feb 08, 2024
BUY
$106.07 - $132.76 $2.53 Million - $3.16 Million
23,831 Added 2.19%
1,113,413 $147 Million
Q3 2023

Oct 24, 2023
SELL
$94.02 - $117.1 $965,961 - $1.2 Million
-10,274 Reduced 0.93%
1,089,582 $123 Million
Q2 2023

Jul 31, 2023
BUY
$89.53 - $104.87 $1.88 Million - $2.2 Million
20,963 Added 1.94%
1,099,856 $104 Million
Q1 2023

May 08, 2023
BUY
$94.11 - $123.02 $1.62 Million - $2.12 Million
17,232 Added 1.62%
1,078,893 $109 Million
Q4 2022

Feb 13, 2023
SELL
$106.72 - $127.06 $1.42 Million - $1.69 Million
-13,265 Reduced 1.23%
1,061,661 $127 Million
Q3 2022

Nov 14, 2022
BUY
$92.03 - $107.81 $473,034 - $554,143
5,140 Added 0.48%
1,074,926 $114 Million
Q2 2022

Nov 14, 2022
BUY
$75.79 - $100.07 $4.63 Million - $6.11 Million
61,036 Added 6.05%
1,069,786 $104 Million
Q2 2022

Sep 13, 2022
BUY
$75.79 - $100.07 $38,728 - $51,135
511 Added 0.05%
1,031,504 $101 Million
Q2 2022

Aug 02, 2022
BUY
$75.79 - $100.07 $4.38 Million - $5.78 Million
57,737 Added 5.93%
1,030,993 $100 Million
Q1 2022

Nov 14, 2022
SELL
$72.45 - $94.81 $1.65 Million - $2.16 Million
-22,754 Reduced 2.21%
1,008,750 $94.6 Million
Q1 2022

Sep 13, 2022
SELL
$72.45 - $94.81 $14,707 - $19,246
-203 Reduced 0.02%
973,256 $91.2 Million
Q1 2022

May 09, 2022
BUY
$72.45 - $94.81 $2.68 Million - $3.51 Million
36,975 Added 3.95%
973,459 $91.2 Million
Q4 2021

Jan 27, 2022
BUY
$79.65 - $106.22 $11.4 Million - $15.2 Million
143,477 Added 18.09%
936,484 $79.8 Million
Q3 2021

Nov 12, 2021
BUY
$86.18 - $99.03 $1.26 Million - $1.45 Million
14,661 Added 1.88%
793,007 $76.1 Million
Q2 2021

Jul 29, 2021
BUY
$89.43 - $102.27 $1.24 Million - $1.42 Million
13,887 Added 1.82%
778,346 $75.7 Million
Q1 2021

May 14, 2021
BUY
$87.57 - $119.4 $5.84 Million - $7.97 Million
66,729 Added 9.56%
764,459 $74.3 Million
Q4 2020

Feb 12, 2021
BUY
$86.91 - $108.33 $4.74 Million - $5.91 Million
54,588 Added 8.49%
697,730 $66.9 Million
Q3 2020

Nov 16, 2020
BUY
$96.16 - $135.15 $1.7 Million - $2.39 Million
17,707 Added 2.83%
643,142 $61.8 Million
Q2 2020

Aug 14, 2020
BUY
$85.09 - $130.36 $1.78 Million - $2.73 Million
20,960 Added 3.47%
625,435 $76.3 Million
Q1 2020

May 15, 2020
BUY
$75.11 - $113.76 $3.12 Million - $4.72 Million
41,489 Added 7.37%
604,475 $52.3 Million
Q4 2019

Feb 14, 2020
BUY
$86.8 - $118.57 $301,456 - $411,793
3,473 Added 0.62%
562,986 $60.5 Million
Q3 2019

Nov 14, 2019
BUY
$83.82 - $101.5 $2.12 Million - $2.56 Million
25,268 Added 4.73%
559,513 $50.4 Million
Q2 2019

Aug 12, 2019
BUY
$72.24 - $91.27 $11.5 Million - $14.5 Million
158,858 Added 42.32%
534,245 $45.1 Million
Q1 2019

May 15, 2019
BUY
$69.31 - $91.53 $4.58 Million - $6.04 Million
66,036 Added 21.35%
375,387 $33.1 Million
Q4 2018

Feb 13, 2019
SELL
$68.32 - $124.36 $312,768 - $569,320
-4,578 Reduced 1.46%
309,351 $22.1 Million
Q3 2018

Nov 13, 2018
BUY
$98.88 - $125.85 $1.08 Million - $1.37 Million
10,903 Added 3.6%
313,929 $38.6 Million
Q2 2018

Aug 10, 2018
BUY
$75.3 - $105.99 $1.56 Million - $2.2 Million
20,733 Added 7.34%
303,026 $29.8 Million
Q1 2018

Jun 28, 2018
BUY
$75.88 - $92.43 $9.19 Million - $11.2 Million
121,050 Added 75.07%
282,293 $23.4 Million
Q1 2018

May 14, 2018
SELL
$75.88 - $92.43 $8.81 Million - $10.7 Million
-116,054 Reduced 41.85%
161,243 $13.4 Million
Q4 2017

Feb 12, 2018
BUY
$58.53 - $77.59 $235,583 - $312,299
4,025 Added 1.47%
277,297 $21.5 Million
Q3 2017

Nov 13, 2017
BUY
$47.97 - $61.28 $1.2 Million - $1.54 Million
25,115 Added 10.12%
273,272 $16.7 Million
Q2 2017

Aug 14, 2017
BUY
N/A
248,157
248,157 $11.4 Million

Others Institutions Holding NBIX

# of Institutions
625
Shares Held
94.2M
Call Options Held
632K
Put Options Held
621K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Brown Advisory Inc Portfolio

Follow Brown Advisory Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email